Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, Ding YS, Adam M, Aasly J, Wszolek ZK, Farrer M, Sossi V, Stoessl AJ. Wile DJ, et al. Among authors: schulzer m. Lancet Neurol. 2017 May;16(5):351-359. doi: 10.1016/S1474-4422(17)30056-X. Epub 2017 Mar 20. Lancet Neurol. 2017. PMID: 28336296 Free PMC article.
Dopamine turnover increases in asymptomatic LRRK2 mutations carriers.
Sossi V, de la Fuente-Fernández R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, Aasly JO, Farrer MJ, Wszolek ZK, Stoessl JA. Sossi V, et al. Among authors: schulzer m. Mov Disord. 2010 Dec 15;25(16):2717-23. doi: 10.1002/mds.23356. Mov Disord. 2010. PMID: 20939082
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.
Liu SY, Wile DJ, Fu JF, Valerio J, Shahinfard E, McCormick S, Mabrouk R, Vafai N, McKenzie J, Neilson N, Perez-Soriano A, Arena JE, Cherkasova M, Chan P, Zhang J, Zabetian CP, Aasly JO, Wszolek ZK, McKeown MJ, Adam MJ, Ruth TJ, Schulzer M, Sossi V, Stoessl AJ. Liu SY, et al. Among authors: schulzer m. Lancet Neurol. 2018 Apr;17(4):309-316. doi: 10.1016/S1474-4422(18)30032-2. Epub 2018 Feb 16. Lancet Neurol. 2018. PMID: 29456161 Free PMC article.
Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study.
Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ. Nandhagopal R, et al. Among authors: schulzer m. Neurology. 2008 Nov 25;71(22):1790-5. doi: 10.1212/01.wnl.0000335973.66333.58. Neurology. 2008. PMID: 19029519 Free PMC article.
The placebo effect in neurological disorders.
de la Fuente-Fernández R, Schulzer M, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: schulzer m. Lancet Neurol. 2002 Jun;1(2):85-91. doi: 10.1016/s1474-4422(02)00038-8. Lancet Neurol. 2002. PMID: 12849512 Review.
279 results